Caring approach, proven results

Ferman Milster participates in the Pulmonary Rehabilitation Program at UI Health Care
Pulmonary Rehabilitation Program helps patients improve airway disease symptoms, quality of life Ferman Milster is a believer in the idea that “if something works, stick with it.” For Ferman, “sticking with it” means at least three visits each week to the University of Iowa Health Care Pulmonary...

Focus on obesity-related cancer

According to the Cancer in Iowa 2018 report, scientific evidence exists linking excess body weight to higher risk of several types of cancer.

Running races with ease

April Gross running
April Gross has a new goal: Run a 5K race in under 30 minutes. Prior to her lung transplant, April's lungs were so damaged by cystic fibrosis that crawling into bed left her winded, and her goal was simply to live.

A dandy story

Two Iowans share more than a lifetime of memories, they share a kidney named "Dandy." Learn more about their incredible story today.

Cardiac Rehabilitation to remove CHAMPS acronym

The UI Heart and Vascular Center's Cardiac Rehabilitation program will no longer use the CHAMPS acronym, effective Thursday, March 1.

UI Health Care to raise awareness on colon cancer screening

Colorectal cancer is the third most common cancer in Iowa and the second leading cause of death from cancer, according to the State Health Registry of Iowa. However, the good news is that a simple screening and early detection can help Iowans survive colon cancer and help prevent this deadly disease.

UI spin-off Viewpoint Molecular Targeting wins NIH awards

External Source: 
Carver College of Medicine News
University of Iowa spin-off Viewpoint Molecular Targeting has recently been awarded a $2 million Phase II NIH SBIR to support development of a new treatment for metastatic melanoma.

National Cancer Institute awards research grant renewal to University of Iowa and Mayo Clinic

External Source: 
Carver College of Medicine News
The National Cancer Institute is giving $12.4 million for lymphoma research.

UI clinician spearheading promising melanoma immunotherapy treatment

External Source: 
Carver College of Medicine News
Holden Comprehensive Cancer Center researcher Yousef Zakharia, MD, has presented promising data at a national meeting about combining a new investigational immunotherapy drug with an FDA-approved immunotherapy drug to treat patients with advanced melanoma.

High-dose vitamin C proves safe and well-tolerated in brain and lung cancer trials

External Source: 
Carver College of Medicine News
Evidence is growing that adding high-dose, intravenous vitamin C in combination with standard chemotherapy and radiation treatment is a safe, relatively inexpensive approach that may improve outcomes for patients with a wide range of cancers.